Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7237
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGeyer, Martin-
dc.contributor.authorKeller, Karsten-
dc.contributor.authorBachmann, Kevin-
dc.contributor.authorBorn, Sonja-
dc.contributor.authorTamm, Alexander R.-
dc.contributor.authorRuf, Tobias Friedrich-
dc.contributor.authorKreidel, Felix-
dc.contributor.authorHahad, Omar-
dc.contributor.authorPetrescu, Aniela-
dc.contributor.authorHell, Michaela-
dc.contributor.authorBeiras-Fernandez, Andres-
dc.contributor.authorKornberger, Angela-
dc.contributor.authorSchulz, Eberhard-
dc.contributor.authorMünzel, Thomas-
dc.contributor.authorBardeleben, Ralph Stephan von-
dc.date.accessioned2022-06-28T08:20:59Z-
dc.date.available2022-06-28T08:20:59Z-
dc.date.issued2021-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7251-
dc.description.abstractBACKGROUND Concomitant tricuspid regurgitation (TR) is a common finding in mitral regurgitation (MR). Transcatheter repair (TMVR) is a favorable treatment option in patients at elevated surgical risk. To date, evidence on long-term prognosis and the prognostic impact of TR after TMVR is limited. METHODS Long-term survival data of patients undergoing isolated edge-to-edge repair from June 2010 to March 2018 (combinations with other forms of TMVR or tricuspid valve therapy excluded) were analyzed in a retrospective monocentric study. TR severity was categorized and the impact of TR on survival was analysed. RESULTS Overall, 606 patients [46.5% female, 56.4% functional MR (FMR)] were enrolled in this study. TR at baseline was categorized severe/medium/mild/no or trace in 23.2/34.3/36.3/6.3% of the cases. At 30-day follow-up, improvement of at least one TR-grade was documented in 34.9%. Severe TR at baseline was identified as predictor of 1-year survival [65.2% vs. 77.0%, p = 0.030; HR for death 1.68 (95% CI 1.12–2.54), p = 0.013] and in FMR-patients also regarding long-term prognosis [adjusted HR for long-term mortality 1.57 (95% CI 1.00–2.45), p = 0.049]. Missing post-interventional reduction of TR severity was predictive for poor prognosis, especially in the FMR-subgroup [1-year survival: 92.9% vs. 78.3%, p = 0.025; HR for death at 1-year follow-up 3.31 (95% CI 1.15–9.58), p = 0.027]. While BNP levels decreased in both subgroups, TR reduction was associated with improved symptomatic benefit (NYHA-class-reduction 78.6 vs. 65.9%, p = 0.021). CONCLUSION In this large study, both, severe TR at baseline as well as missing secondary reduction were predictive for impaired long-term prognosis, especially in patients with FMR etiology. TR reduction was associated with increased symptomatic benefit.en_GB
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleConcomitant tricuspid regurgitation severity and its secondary reduction determine long-term prognosis after transcatheter mitral valve edge-to-edge repairen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7237-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleClinical research in cardiologyde
jgu.journal.volume110de
jgu.pages.start676de
jgu.pages.end688de
jgu.publisher.year2021-
jgu.publisher.nameSpringerde
jgu.publisher.placeBerlinde
jgu.publisher.issn1861-0692de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1007/s00392-020-01798-4de
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
concomitant_tricuspid_regurgi-20220627114547951.pdf1.04 MBAdobe PDFView/Open